Lantheus is acquiring radiopharmaceutical CDMO Evergreen Theragnostics in a deal worth up to $1 billion, expanding its manufacturing capabilities and drug pipeline. The acquisition includes Octevy, a ...

Advanced Therapeutics Pharmaceutical Outsourcing IndustryFuture Market Insights (FMI), a leading provider of industry analysis and market research, has unveiled its latest report highlighting the ...

HCLTech aims to retain its $1 billion contract with Volvo Group as Infosys emerges as a strong contender. The negotiators met ...

India's economy is undergoing a significant transformation, with the digital economy projected to add $355 billion to $435 ...

One of the primary drivers behind the adoption of biologics contract manufacturing is the potential for significant cost savings. By outsourcing production to a CDMO, pharmaceutical companies can ...

Intel Corporation is set to face intense investor scrutiny over its ongoing CEO search and turnaround strategy as it prepares to report quarterly earnings on Thursday. The company is grappling with ...

From HCLTech’s side, Ashish Kumar Gupta, Head for EMEA and corporate VP, who was instrumental in stitching the deal 2016, is ...

One positive of the last election is that the Trump administration is pro-US manufacturing and is considering tax incentives to reward companies that manufacture in the US and tariffs to punish ...

As scientific discovery and technology advance, new opportunities arise and business priorities shift throughout the global ...

Baron Small Cap Fund declined in Q4 2024. Who were the top contributors and detractors? Click here to find out.

The "Cell Culture Vessels Market by Product, by Type, by End-User, and By Region" report has been added to ResearchAndMarkets ...